Status:
NOT_YET_RECRUITING
Topical Versus Injection PRP for Olfactory Dysfunction
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Conditions:
Olfactory Dysfunction
Anosmia
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
The goal of this clinical trial is to determine whether two different delivery methods of autologous platelet-rich plasma (PRP) can improve olfactory function in adults with persistent olfactory dysfu...
Detailed Description
Persistent olfactory dysfunction (OD) is a common sequela of viral upper respiratory tract infections, including COVID-19, and can significantly affect patients' quality of life, nutrition, and safety...
Eligibility Criteria
Inclusion
- Aged between 18 and 80 years, regardless of sex
- Subjective complaint of olfactory dysfunction with confirmed hyposmia or anosmia based on standardized olfactory testing
- History of at least 3 months of prior olfactory training but with persistent olfactory complaints
Exclusion
- Congenital anosmia
- Diagnosed neurological or structural brain abnormalities (e.g., brain tumor, major head trauma, stroke) with low likelihood of olfactory recovery
- Inability or unwillingness to comply with study procedures or follow-up assessments
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07151703
Start Date
October 1 2025
End Date
December 31 2028
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Veterans General Hospital
Taipei, Taiwan, 112201